Amgen Inc

Stock Chart, Company Information, and Scan Results

$289.33(as of Aug 13, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Amgen Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$289.33
Ticker SymbolAMGN
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees28,000
CountyUSA
Market Cap$153,422.4M
EBIDTA16,054.0M
10-Day Moving Average291.10
P/E Ratio23.65
20-Day Moving Average296.81
Forward P/E Ratio13.81
50-Day Moving Average292.89
Earnings per Share12.23
200-Day Moving Average287.23
Profit Margin15.62%
RSI45.79
Shares Outstanding538.4M
ATR6.73
52-Week High332.94
Volume1,784,842
52-Week Low249.07
Most Recent Support Level282.60
Book Value7,428.0M
Most Recent Resistance Level291.74
P/B Ratio21.07
Upper Keltner311.94
P/S Ratio4.48
Lower Keltner281.67
Debt-to-Equity Ratio311.94
Next Earnings Date10/28/2025
Cash Surplus-12,448.0M
Next Ex-Dividend Date08/22/2025

Amgen is a leader in medicinal breakthroughs as it pioneered ways to use living cells to develop biological medicines. The biotech develops and commercializes drugs to treat conditions like cancer, cardiovascular disease, and bone health. The company’s top-selling drugs, Aranesp and Kyprolis, are used to treat anemia and cancer respectively.

Amgen Inc In Our Stock Scanner

As of Aug 14, 2025
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.